Menu

The Journey From Features To Compound Identification In Metabolomics: When Will We Get There?

In this eBook, learn about advancements in untargeted metabolomic workflow, including improved standards, guidelines, databases, and more!

Jul 13, 2018
The Scientist Creative Services Team

A relatively new field on the rise, metabolomics is breaking ground identifying metabolites, giving a better understanding of what has happened and is happening within an organism. One roadblock to this research is the bottleneck of untargeted metabolites which all but prevents biological interpretation. However, thanks to a concerted effort among researchers, metabolomics is seeing gains in compound identification through improved reporting standards, better instrumentation, in silico advancements, and data interpretation guidelines.

Download this eBook from The Scientist to find out more about: 
• Data Reduction Strategies
• Guidelines for Compound Identification
• Advancement of Databases and Libraries
• Untargeted Metabolomics Workflow
• Problems with Standards • Structural Elucidation Strategies

This free eBook was made possible by an educational grant from Thermo Fisher Scientific.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.